Hofseth Biocare
Hofseth Biocare ASA, commonly referred to as Hofseth Biocare, is a leading player in the biotechnology and health supplement industry, headquartered in Norway. Founded in 2009, the company has established itself as a pioneer in the development of high-quality marine ingredients, focusing on sustainable practices and innovative extraction methods. With operations primarily in Norway and a growing presence in international markets, Hofseth Biocare offers a range of unique products, including omega-3 fatty acids, collagen peptides, and other bioactive compounds derived from fish. Their commitment to sustainability and quality has positioned them as a trusted supplier in the health and wellness sector, earning recognition for their advanced research and development initiatives. As a result, Hofseth Biocare continues to make significant strides in promoting health through marine biotechnology.
DitchCarbon Score
How does Hofseth Biocare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hofseth Biocare's score of 41 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hofseth Biocare's reported carbon emissions
In 2023, Hofseth Biocare reported total carbon emissions of approximately 9,653,000 kg CO2e, with Scope 1 emissions at about 1,850,000 kg CO2e, Scope 2 emissions at around 46,000 kg CO2e, and Scope 3 emissions contributing approximately 7,757,000 kg CO2e. This reflects a significant commitment to transparency in their carbon footprint across all scopes. In 2022, the company’s emissions were approximately 13,403,000 kg CO2e, with Scope 1 emissions at about 2,104,000 kg CO2e, Scope 2 at approximately 4,761,000 kg CO2e, and Scope 3 at around 6,538,000 kg CO2e. This indicates a reduction in total emissions from 2022 to 2023. For the year 2021, Hofseth Biocare's emissions were reported at approximately 1,810,000 kg CO2e for Scope 1 and 45,000 kg CO2e for Scope 2, totalling about 1,855,000 kg CO2e for these scopes. The company has not disclosed specific reduction targets or initiatives, indicating a potential area for future commitment. Hofseth Biocare's emissions data highlights their ongoing efforts to monitor and report on their carbon footprint, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 1,619,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 90,400 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hofseth Biocare is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
